810 related articles for article (PubMed ID: 10369850)
1. Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2.
Eisenhofer G; Lenders JW; Linehan WM; Walther MM; Goldstein DS; Keiser HR
N Engl J Med; 1999 Jun; 340(24):1872-9. PubMed ID: 10369850
[TBL] [Abstract][Full Text] [Related]
2. Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease.
Neumann HP; Berger DP; Sigmund G; Blum U; Schmidt D; Parmer RJ; Volk B; Kirste G
N Engl J Med; 1993 Nov; 329(21):1531-8. PubMed ID: 8105382
[TBL] [Abstract][Full Text] [Related]
3. How to detect pheochromocytomas?--the diagnostic relevance of plasma free metanephrines.
Roden M
Wien Klin Wochenschr; 2002 Apr; 114(7):246-51. PubMed ID: 12089859
[TBL] [Abstract][Full Text] [Related]
4. Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes.
Eisenhofer G; Walther MM; Huynh TT; Li ST; Bornstein SR; Vortmeyer A; Mannelli M; Goldstein DS; Linehan WM; Lenders JW; Pacak K
J Clin Endocrinol Metab; 2001 May; 86(5):1999-2008. PubMed ID: 11344198
[TBL] [Abstract][Full Text] [Related]
5. Comparison of plasma metanephrines measured by a commercial immunoassay and urinary catecholamines in the diagnosis of pheochromocytoma.
Christensen TT; Frystyk J; Poulsen PL
Scand J Clin Lab Invest; 2011 Dec; 71(8):695-700. PubMed ID: 22023043
[TBL] [Abstract][Full Text] [Related]
6. Utility of plasma free metanephrines for detecting childhood pheochromocytoma.
Weise M; Merke DP; Pacak K; Walther MM; Eisenhofer G
J Clin Endocrinol Metab; 2002 May; 87(5):1955-60. PubMed ID: 11994324
[TBL] [Abstract][Full Text] [Related]
7. Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma.
Eisenhofer G; Lenders JW; Timmers H; Mannelli M; Grebe SK; Hofbauer LC; Bornstein SR; Tiebel O; Adams K; Bratslavsky G; Linehan WM; Pacak K
Clin Chem; 2011 Mar; 57(3):411-20. PubMed ID: 21262951
[TBL] [Abstract][Full Text] [Related]
8. Pheochromocytoma as the first manifestation of von Hippel-Lindau disease.
Richard S; Beigelman C; Duclos JM; Fendler JP; Plauchu H; Plouin PF; Resche F; Schlumberger M; Vermesse B; Proye C
Surgery; 1994 Dec; 116(6):1076-81. PubMed ID: 7985090
[TBL] [Abstract][Full Text] [Related]
9. Overnight excretion of urinary catecholamines and metabolites in the detection of pheochromocytoma.
Peaston RT; Lennard TW; Lai LC
J Clin Endocrinol Metab; 1996 Apr; 81(4):1378-84. PubMed ID: 8636337
[TBL] [Abstract][Full Text] [Related]
10. Levodopa therapy in Parkinson's disease: influence on liquid chromatographic tandem mass spectrometric-based measurements of plasma and urinary normetanephrine, metanephrine and methoxytyramine.
Eisenhofer G; Brown S; Peitzsch M; Pelzel D; Lattke P; Glöckner S; Stell A; Prejbisz A; Fassnacht M; Beuschlein F; Januszewicz A; Siegert G; Reichmann H
Ann Clin Biochem; 2014 Jan; 51(Pt 1):38-46. PubMed ID: 23873873
[TBL] [Abstract][Full Text] [Related]
11. Perioperative outcomes of syndromic paraganglioma and pheochromocytoma resection in patients with von Hippel-Lindau disease, multiple endocrine neoplasia type 2, or neurofibromatosis type 1.
Butz JJ; Yan Q; McKenzie TJ; Weingarten TN; Cavalcante AN; Bancos I; Young WF; Schroeder DR; Martin DP; Sprung J
Surgery; 2017 Dec; 162(6):1259-1269. PubMed ID: 28919049
[TBL] [Abstract][Full Text] [Related]
12. Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines.
Eisenhofer G; Lenders JW; Goldstein DS; Mannelli M; Csako G; Walther MM; Brouwers FM; Pacak K
Clin Chem; 2005 Apr; 51(4):735-44. PubMed ID: 15718487
[TBL] [Abstract][Full Text] [Related]
13. Changes in urinary total metanephrine excretion in recurrent and malignant pheochromocytomas and secreting paragangliomas.
Amar L; Peyrard S; Rossignol P; Zinzindohoue F; Gimenez-Roqueplo AP; Plouin PF
Ann N Y Acad Sci; 2006 Aug; 1073():383-91. PubMed ID: 17102107
[TBL] [Abstract][Full Text] [Related]
14. The diagnostic efficacy of urinary fractionated metanephrines measured by tandem mass spectrometry in detection of pheochromocytoma.
Perry CG; Sawka AM; Singh R; Thabane L; Bajnarek J; Young WF
Clin Endocrinol (Oxf); 2007 May; 66(5):703-8. PubMed ID: 17388796
[TBL] [Abstract][Full Text] [Related]
15. Islet cell tumors in von Hippel-Lindau disease: increased prevalence and relationship to the multiple endocrine neoplasias.
Binkovitz LA; Johnson CD; Stephens DH
AJR Am J Roentgenol; 1990 Sep; 155(3):501-5. PubMed ID: 1974734
[TBL] [Abstract][Full Text] [Related]
16. Pheochromocytoma: inherited associations, bilaterality, and cortex preservation.
Inabnet WB; Caragliano P; Pertsemlidis D
Surgery; 2000 Dec; 128(6):1007-11;discussion 1011-2. PubMed ID: 11114636
[TBL] [Abstract][Full Text] [Related]
17. Circulating and urinary catecholamines in pheochromocytoma. Diagnostic and pathophysiologic implications.
Bravo EL; Tarazi RC; Gifford RW; Stewart BH
N Engl J Med; 1979 Sep; 301(13):682-6. PubMed ID: 481462
[TBL] [Abstract][Full Text] [Related]
18. Lessons from an unpleasant surprise: a biochemical strategy for the diagnosis of pheochromocytoma.
Gardet V; Gatta B; Simonnet G; Tabarin A; Chêne G; Ducassou D; Corcuff JB
J Hypertens; 2001 Jun; 19(6):1029-35. PubMed ID: 11403350
[TBL] [Abstract][Full Text] [Related]
19. Urinary and plasma catecholamines and urinary catecholamine metabolites in pheochromocytoma: diagnostic value in 19 cases.
Gerlo EA; Sevens C
Clin Chem; 1994 Feb; 40(2):250-6. PubMed ID: 7906208
[TBL] [Abstract][Full Text] [Related]
20. Clinical and genetic characterization of pheochromocytoma in von Hippel-Lindau families: comparison with sporadic pheochromocytoma gives insight into natural history of pheochromocytoma.
Walther MM; Reiter R; Keiser HR; Choyke PL; Venzon D; Hurley K; Gnarra JR; Reynolds JC; Glenn GM; Zbar B; Linehan WM
J Urol; 1999 Sep; 162(3 Pt 1):659-64. PubMed ID: 10458336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]